Middle East Journal of Rehabilitation and Health

Published by: Kowsar

Association Between MspI Polymorphisms of the Apolipoprotein A-I Gene and Hyperlipidemia in an Iranian Population

Abbas Pakdel 1 , 2 , Mohammad Reza Akbari Eidgahi 3 and Ahmad R. Bandegi 1 , 2 , *
Authors Information
1 Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
2 Department of Biochemistry, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, IR Iran
3 Biotechnology Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
Article information
  • Middle East Journal of Rehabilitation and Health: January 2018, 5 (1); e60496
  • Published Online: January 13, 2018
  • Article Type: Research Article
  • Received: August 23, 2017
  • Revised: November 20, 2017
  • Accepted: November 28, 2017
  • DOI: 10.5812/mejrh.60496

To Cite: Pakdel A, Akbari Eidgahi M R, Bandegi A R. Association Between MspI Polymorphisms of the Apolipoprotein A-I Gene and Hyperlipidemia in an Iranian Population, Middle East J Rehabil Health Stud. 2018 ; 5(1):e60496. doi: 10.5812/mejrh.60496.

Abstract
Copyright © 2017, Middle East Journal of Rehabilitation and Health Studies. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195-211. doi: 10.1016/j.pop.2012.11.003. [PubMed: 23402469].
  • 2. Agnoli C, Grioni S, Sieri S, Sacerdote C, Vineis P, Tumino R, et al. Colorectal cancer risk and dyslipidemia: a case-cohort study nested in an Italian multicentre cohort. Cancer Epidemiol. 2014;38(2):144-51. doi: 10.1016/j.canep.2014.02.002. [PubMed: 24636241].
  • 3. Yao X, Tian Z. Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control. 2015;26(2):257-68. doi: 10.1007/s10552-014-0507-y. [PubMed: 25488827].
  • 4. Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016;65(8):1109-23. doi: 10.1016/j.metabol.2016.05.003. [PubMed: 27237577].
  • 5. Cole CB, Nikpay M, McPherson R. Gene-environment interaction in dyslipidemia. Curr Opin Lipidol. 2015;26(2):133-8. doi: 10.1097/MOL.0000000000000160. [PubMed: 25692343].
  • 6. Ebrahimi H, Emamian MH, Hashemi H, Fotouhi A. Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study. Diabetes Metab Syndr. 2016;10(3):149-56. doi: 10.1016/j.dsx.2016.01.009. [PubMed: 27033172].
  • 7. Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med. 2014;5(4):373-93. [PubMed: 24829725].
  • 8. Bandegi AR, Firoozrai M, Ehsani Zonouz A, Akbari Eidgahi MR, Shabani AA, Malek M. Study of XmnI polymorphism in 5´ region of the apoAI gene in Iranian hyperlipidemic subjects. Koomesh J. 2004;6(1):63-70.
  • 9. Bandegi AR, Firoozrai M, Akbari Eidgahi MR, Kokhaei P. SstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province. Iran J Basic Med Sci. 2011;14(6):506-13. [PubMed: 23493241].
  • 10. Bandegi AR, Firoozray M, Akbari-Eydgahi MR. Association between Lipoprotein Lipase Hind III Polymorphism and Serum Levels of Lipids in Semnan City. J Kerman Univ Med Sci. 2012;19(3):233-42.
  • 11. Walldius G, Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J. 2005;26(3):210-2. doi: 10.1093/eurheartj/ehi077. [PubMed: 15618031].
  • 12. Dong H, Chen W, Wang X, Pi F, Wu Y, Pang S, et al. Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study. Metab Brain Dis. 2015;30(6):1319-30. doi: 10.1007/s11011-015-9732-7. [PubMed: 26363640].
  • 13. Bora K, Pathak MS, Borah P, Hussain MI, Das D. Single nucleotide polymorphisms of APOA1 gene and their relationship with serum apolipoprotein A-I concentrations in the native population of Assam. Meta Gene. 2016;7:20-7. doi: 10.1016/j.mgene.2015.10.005. [PubMed: 26702398].
  • 14. Daneshpour MS, Faam B, Mansournia MA, Hedayati M, Halalkhor S, Mesbah-Namin SA, et al. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study. Endocrine. 2012;41(1):103-10. doi: 10.1007/s12020-011-9526-6. [PubMed: 22105741].
  • 15. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE, Hamman RF. Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo AI and HDL-cholesterol. Atheroscler. 1996;127(2):255-62.
  • 16. Feng DW, Ma RL, Guo H, He J, Yan YZ, et al.Muratbek. Association of APOA1 gene polymorphisms (rs670, rs5069, and rs2070665) with dyslipidemia in the Kazakhs of Xinjiang. Genet Mol Res. 2016;15(2). doi: 10.4238/gmr.15028094. [PubMed: 27173266].
  • 17. Chen ES, Mazzotti DR, Furuya TK, Cendoroglo MS, Ramos LR, Araujo LQ, et al. Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity. Clin Exp Med. 2009;9(4):319-25. doi: 10.1007/s10238-009-0051-3. [PubMed: 19408098].
  • 18. Toptas B, Gormus U, Ergen A, Gurkan H, Kelesoglu F, Darendeliler F, et al. Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia. In Vivo. 2011;25(3):425-30. [PubMed: 21576418].
  • 19. Dawar R, Gurtoo A, Singh R. Apolipoprotein A1 Gene Polymorphism (G-75a and C+83t) in Myocardial Infarction-a Pilot Study in the North Indian Population. Atheroscler. 2009;207(1):E12-E3.
  • 20. Dawar R, Gurtoo A, Singh R. Apolipoprotein A1 gene polymorphism (G-75A and C+83T) in patients with myocardial infarction: a pilot study in a north Indian population. Am J Clin Pathol. 2010;134(2):249-55. doi: 10.1309/AJCPKPTXQ3QN1IFG. [PubMed: 20660328].
  • 21. Ding Y, Zhu MA, Wang ZX, Zhu J, Feng JB, Li DS. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome. J Biomed Biotechnol. 2012;2012:509420. doi: 10.1155/2012/509420. [PubMed: 22675253].
  • 22. Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Laakso M. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care. 2000;23(6):791-5. [PubMed: 10840998].
  • 23. Morcillo S, Cardona F, Rojo-Martinez G, Esteva I, De Adana MSR, Tinahones F. Association between MspI polymorphism of the Apo AI gene and type 2 diabetes mellitus. Diabet. 2004;53:A541-A.
  • 24. Wu Y, Yu Y, Zhao T, Wang S, Fu Y, Qi Y, et al. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome. PLoS One. 2016;11(1). e0147946. doi: 10.1371/journal.pone.0147946. [PubMed: 26824674].
  • 25. Sorkin SC, Forestiero FJ, Hirata MH, Guzman EC, Cavalli SA, Bertolami MC, et al. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. Clin Chem Lab Med. 2005;43(12):1339-45. doi: 10.1515/CCLM.2005.229. [PubMed: 16309370].
  • 26. Al-Bustan SA, Al-Serri AE, Annice BG, Alnaqeeb MA, Ebrahim GA. Re-sequencing of the APOAI promoter region and the genetic association of the -75G > A polymorphism with increased cholesterol and low density lipoprotein levels among a sample of the Kuwaiti population. BMC Med Genet. 2013;14:90. doi: 10.1186/1471-2350-14-90. [PubMed: 24028463].
  • 27. Bandarian F, Hedayati M, Daneshpour MS, Naseri M, Azizi F. Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels. Lipids. 2013;48(12):1207-16. doi: 10.1007/s11745-013-3847-6. [PubMed: 24081495].
  • 28. Pakdel A, Akbari eydgahi MR, Bandegi AR. Lack of association between PstI polymorphism in the 3' flanking region of the apolipoprotein AI gene and serum lipids levels in an Iranian population. Koomesh J. 2017;19(3):619-25.
  • 29. Sakri FH, Mokhsin NAM, Ahmad WNHW, Rahman TA, Hoh BP, Nawawi HM. Genetic Association of Single Nucleotide Polymorphisms of Abca1, Apoa1 and Lcat Genes in Subjects with Low Concentration of High Density Lipoprotein-Cholesterol. Atheroscl. 2015;241(1):E109-E.
  • 30. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein‐lipid levels in African blacks. Genetic Epidemiol. 1999;16(2):205-22.
  • 31. Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, et al. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels. Clin Genet. 2002;61(3):176-84. [PubMed: 12000358].
  • 32. Shanker J, Perumal G, Rao VS, Khadrinarasimhiah NB, John S, Hebbagodi S, et al. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis. 2008;7:33. doi: 10.1186/1476-511X-7-33. [PubMed: 18801202].
  • 33. Bai H, Saku K, Liu R, Jimi S, Arakawa K. Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease. J Cardiol. 1996;28(4):207-12. [PubMed: 8934336].
  • 34. Biswas S, Ghoshal PK, Halder B, Ganguly K, DasBiswas A, Mandal N. Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India. Indian Heart J. 2013;65(6):658-65. doi: 10.1016/j.ihj.2013.10.003. [PubMed: 24407534].
  • 35. Heng CK, Low PS, Saha N. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr Res. 2001;49(4):514-8. doi: 10.1203/00006450-200104000-00013. [PubMed: 11264435].
  • 36. Sigurdsson G, Gudnason V, Humphries SE. Interaction between a polymorphism of the apo AI promoter region and smoking determines plasma levels of HDL and apo AI. Arterioscl Thrombos Vascul Biol. 1992;12(9):1017-22.
  • 37. Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res. 1996;37(1):136-47. [PubMed: 8820109].
  • 38. Jeenah M, Kessling A, Miller N, Humphries S. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990;7(3):233-41. [PubMed: 1977072].
  • 39. Rai TS, Khullar M, Sehrawat BS, Ahuja M, Sharma PK, Vijayvergiya R, et al. Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. Mol Cell Biochem. 2008;313(1-2):139-46. doi: 10.1007/s11010-008-9751-3. [PubMed: 18398670].
  • 40. Talmud PJ, Ye S, Humphries SE. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study. Genet Epidemiol. 1994;11(3):265-80. doi: 10.1002/gepi.1370110305. [PubMed: 8088507].
  • 41. de Franca E, Alves JG, Hutz MH. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Brazilian J Med Biologic Res. 2005;38(4):535-41.
  • 42. Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Int J Clinic Chem. 2005;360(1-2):37-45.
  • 43. Padmaja N, Kumar MR, Adithan C. Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population. Indian Heart J. 2009;61(1):51-4. [PubMed: 19729689].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments